Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Ariosa Diagnostics, Inc.
SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony™ Prenatal Test, announced today that it has been selected as a key provider of non-invasive prenatal testing (NIPT) services in the majority of the 28 comprehensive Prenatal Diagnosis Centers (PDC) throughout the State of California. The Harmony test, which is the most widely used NIPT globally, is being offered to pregnant women as part of the California Prenatal Screening Program at no additional cost, subject to the program requirements.
Currently, the California Prenatal Screening Program offers traditional serum and neural tube defect screening to the general population of pregnant women. Patients found to be screen positive for possible chromosome conditions (such as Down syndrome or trisomy 18), or have an increased nuchal translucency measurement, are referred for other services that include genetic counseling, ultrasound, amniocentesis and chorionic villus sampling (CVS). Given its increased sensitivity and specificity, the State has now introduced NIPT as another option in evaluating patients who have an increased risk for chromosome conditions based on their serum screening results.
The Harmony test has the most published data of any NIPT available for pregnant women of any age, fetal gestational age and risk-profile. Published in over 13 peer-reviewed studies, involving thousands of patients, the test has demonstrated greater than 99% accuracy for Down syndrome with a less than 0.1% false positive rate, thereby diminishing the potential for women to unnecessarily proceed to invasive diagnostic procedures that may result in pregnancy complications in an otherwise normal fetus.
About Ariosa Diagnostics
Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the HarmonyTM Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The HarmonyTM Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.
The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com. Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.
©2012 PR Newswire. All Rights Reserved.